Wednesday, June 4, 2014

Earnings Scheduled For October 1, 2013

Actuant (NYSE: ATU) is expected to report its Q4 earnings at $0.50 per share on revenue of $328.79 million.

Acuity Brands (NYSE: AYI) is estimated to report its Q4 earnings at $$1.02 per share on revenue of $569.33 million.

Walgreen Co (NYSE: WAG) is projected to report its Q4 earnings at $0.72 per share on revenue of $17.95 billion.

Global Payments (NYSE: GPN) is expected to post its Q1 earnings at $0.95 per share on revenue of $623.79 million.

Synergetics USA (NASDAQ: SURG) is projected to post its Q4 earnings at $0.06 per share on revenue of $17.01 million.

Team (NYSE: TISI) is expected to post its Q1 earnings at $0.36 per share on revenue of $176.70 million.

Resources Connection (NASDAQ: RECN) is estimated to post its Q1 earnings at $0.12 per share on revenue of $133.43 million.

Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  Around the Web, We're Loving... Petition urges Wal-Mart, McDonald's to pay more Obama's Syria Waffle Huge Blow to US Credibility in Mideast Microsoft Buys Nokia Phone Unit for $7.2B - And CEO? What Should You Know About AMZN? Most Popular iPad Mini 2 Rumor Roundup The Pending U.S. Government Shutdown: What Does It Mean For You? Bargain Shopping the S&P 500 World's Favorite Game Maker to IPO UPDATE: Credit Suisse Lowers PT on Arena Pharmaceuticals Following Management Meeting JC Penney Continues To Search For A Bottom As Shares Hit 31-Year Low Related Articles (ATU + AYI) Stocks To Watch For October 1, 2013 Earnings Expectations For The Week Of September 30: Walgreen, Monsanto And More Benzinga Weekly Preview: Italian Senate To Decide Berlusconi's Fate UPDATE: Goldman Sachs Initiates Acuity Brandsat Neutral Awaiting Better Entry Point Benzinga's Top Initiations UPDATE: Stifel Nicolaus Raises PT on Actuant Following Viking SeaTech Acquisition Announcement View the discussion thread. Partner Network

No comments:

Post a Comment